News & Views | Published:

In vivo veritas

Subjects

Dendritic cells transplanted into patients for cancer immunotherapy can be tracked by MRI.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Schuler, G. et al. Curr Opin. Immunol. 15, 138–147 (2003)

  2. 2

    de Vries, I.J. et al. Nat. Biotechnol. 23, 1407–1413 (2005).

  3. 3

    Steinman, R.M. Annu. Rev. Immunol. 9, 271–296 (1991).

  4. 4

    Bonifaz, L.C. et al. J. Exp. Med. 199, 815–824 (2004).

  5. 5

    Tacken, P.J. et al. Blood 106, 1278–1285 (2005).

  6. 6

    Bousso, P. & Robey E. Nat. Immunol. 4, 579–585 (2003).

  7. 7

    de Vries, I.J. et al. Cancer Res. 63, 12–17 (2003).

  8. 8

    Adema, G.J. et al. Curr. Opin. Immunol. 17, 170–174 (2005).

  9. 9

    Garg, S. et al. Nat. Immunol. 4, 907–912 (2003).

  10. 10

    Bedrosian, I. et al. J. Clin. Oncol. 21, 3826–3835 (2003).

Download references

Author information

Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.

About this article

Figure 1: The pathway of dendritic cell immunotherapy.

Bob Crimi